American Regent, a U.S. manufacturer of pharmaceuticals with manufacturing sites in New York and Ohio, will acquire Daiichi Sankyo Altkirch SARL, a Daiichi Sankyo company that has an active pharmaceutical ingredient (API) pharmaceutical manufacturing plant in Altkirch, France. The facility, previously owned by Daiichi Sankyo Europe, an affiliate of American Regent, produces the API for Adequan i.m. and Adequan Canine. Adequan is an FDA-approved PSGAG (polysulfated glycosaminoglycan) with formula...